143 related articles for article (PubMed ID: 2008214)
1. Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.
Anderson RM; Gupta S; May RM
Nature; 1991 Mar; 350(6316):356-9. PubMed ID: 2008214
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
Musicco M; Lazzarin A; Nicolosi A; Gasparini M; Costigliola P; Arici C; Saracco A
Arch Intern Med; 1994 Sep; 154(17):1971-6. PubMed ID: 8074601
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
Schnittman SM; Fauci AS
Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958
[TBL] [Abstract][Full Text] [Related]
4. [The pathogenicity of the human immunodeficiency virus HIV-2 as seen by epidemiologists].
Soro BN; Gershy-Damet GM; Rey JL
Med Trop (Mars); 1993; 53(1):45-53. PubMed ID: 8505887
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell responsiveness to gp120 of human immunodeficiency virus.
McKallip RJ; Nagarkatti M; Nagarkatti PS
Toxicol Appl Pharmacol; 1995 Mar; 131(1):53-62. PubMed ID: 7878678
[TBL] [Abstract][Full Text] [Related]
6. A two-sex model for treatment of HIV/AIDS and behaviour change in a population of varying size.
Hsieh YH
IMA J Math Appl Med Biol; 1996 Sep; 13(3):151-73. PubMed ID: 8921587
[TBL] [Abstract][Full Text] [Related]
7. HIV/AIDS following sexual assault in Jamaican children and adolescents: a case for HIV post-exposure prophylaxis.
Steel-Duncan JC; Pierre R; Evans-Gilbert T; Rodriquez B; Christie CD
West Indian Med J; 2004 Oct; 53(5):352-5. PubMed ID: 15675503
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro.
Yang JY; Schwartz A; Henderson EE
Biochem Biophys Res Commun; 1994 Jun; 201(3):1424-32. PubMed ID: 8024587
[TBL] [Abstract][Full Text] [Related]
9. Statistical modelling of the AIDS epidemic for forecasting health care needs.
Brookmeyer R; Liao JG
Biometrics; 1990 Dec; 46(4):1151-63. PubMed ID: 2085630
[TBL] [Abstract][Full Text] [Related]
10. [AIDS in Africa].
Sansone R; Carobbi S; Alloro G; Strigini P
Ann Ig; 1989; 1(5):1057-66. PubMed ID: 2483891
[TBL] [Abstract][Full Text] [Related]
11. Sexually-transmitted disease risk in a Micronesian atoll population.
Brewis AA
Health Transit Rev; 1992 Oct; 2(2):195-213. PubMed ID: 10148657
[TBL] [Abstract][Full Text] [Related]
12. Horizontal versus vertical transmission of human immunodeficiency virus type 1 (HIV-1). Experience from southwestern Saudi Arabia.
al-Nozha MM; al-Frayh AR; al-Nasser M; Ramia S
Trop Geogr Med; 1995; 47(6):293-5. PubMed ID: 8650743
[TBL] [Abstract][Full Text] [Related]
13. Potential public health impact of imperfect HIV type 1 vaccines.
Anderson R; Hanson M
J Infect Dis; 2005 Feb; 191 Suppl 1():S85-96. PubMed ID: 15627235
[TBL] [Abstract][Full Text] [Related]
14. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
15. [Sexually transmitted diseases, HIV infection and AIDS in Mudzi, Zimbabwe. A study of knowledge, attitudes and practice in a rural area in southern Africa].
Rygnestad T; Hana J; Myhre AK
Tidsskr Nor Laegeforen; 1994 Apr; 114(9):1045-9. PubMed ID: 8009514
[TBL] [Abstract][Full Text] [Related]
16. The AIDS epidemic: profiles of development.
Haukenes G; Nome S
J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):147-54. PubMed ID: 2212636
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
[TBL] [Abstract][Full Text] [Related]
18. [Surfactants as agents for the individual prevention of HIV/AIDS].
Krivorutchenko IuL
Mikrobiol Z; 1999; 61(1):95-103. PubMed ID: 10330875
[TBL] [Abstract][Full Text] [Related]
19. Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview.
Clumeck N; Hermans P
Am J Med; 1988 Aug; 85(2A):165-72. PubMed ID: 2457313
[TBL] [Abstract][Full Text] [Related]
20. Primary care of women infected with the human immunodeficiency virus.
Allen MH
Obstet Gynecol Clin North Am; 1990 Sep; 17(3):557-69. PubMed ID: 2247290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
